Episurf Medical AB (publ) Cash Flow Conversion Efficiency
Episurf Medical AB (publ) cash flow conversion efficiency. Based on the latest financial reports, Episurf Medical AB (publ) (EPIS-B) has a cash flow conversion efficiency ratio of -0.244x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Skr-11.60 Million ≈ $-1.25 Million USD) by net assets (Skr47.50 Million ≈ $5.11 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cash Flow Conversion Efficiency of Episurf Medical AB (publ) (2010–2025)
Cash flow conversion efficiency of Episurf Medical AB (publ) from 2010 to 2025. This chart illustrates how Episurf Medical AB (publ)'s cash flow conversion efficiency has evolved over time, based on yearly financial data. View Episurf Medical AB (publ) stock price for real-time trading data and today's change.
Episurf Medical AB (publ) Cash Flow Conversion Ratio Explained
Episurf Medical AB (publ) cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
Episurf Medical AB (publ) Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Episurf Medical AB (publ) ranked by their cash flow conversion efficiency. Also see Episurf Medical AB (publ) market cap and net worth for the company's overall valuation and market capitalisation.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Ryvyl Inc
NASDAQ:RVYL
|
0.948x |
|
Shyam Century Ferrous Limited
NSE:SHYAMCENT
|
-0.476x |
|
Solution Engineering Holdings Bhd
KLSE:0093
|
0.004x |
|
Asuransi Bina Dana Arta Tbk
JK:ABDA
|
0.018x |
|
ENTYR Ltd
AU:ETR
|
0.167x |
|
ICG Enterprise Trust PLC
LSE:ICGT
|
-0.010x |
|
KGW Group Berhad
KLSE:0282
|
-0.015x |
|
Strikepoint Gold Inc
V:SKP
|
1.870x |
Annual Cash Flow Conversion Efficiency for Episurf Medical AB (publ) (2010–2025)
The table below shows the annual cash flow conversion efficiency of Episurf Medical AB (publ) from 2010 to 2025. Review EPIS-B cash flow after capex ratio to assess how much free cash flow the company generates relative to operating cash flow.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | Skr47.50 Million ≈ $5.11 Million |
Skr-55.30 Million ≈ $-5.95 Million |
-1.164x | -36.64% |
| 2024-12-31 | Skr83.80 Million ≈ $9.02 Million |
Skr-71.40 Million ≈ $-7.68 Million |
-0.852x | +15.10% |
| 2023-12-31 | Skr84.50 Million ≈ $9.09 Million |
Skr-84.80 Million ≈ $-9.13 Million |
-1.004x | -156.59% |
| 2022-12-31 | Skr177.70 Million ≈ $19.12 Million |
Skr-69.50 Million ≈ $-7.48 Million |
-0.391x | -65.62% |
| 2021-12-31 | Skr252.80 Million ≈ $27.21 Million |
Skr-59.70 Million ≈ $-6.42 Million |
-0.236x | +26.01% |
| 2020-12-31 | Skr169.50 Million ≈ $18.24 Million |
Skr-54.10 Million ≈ $-5.82 Million |
-0.319x | +77.68% |
| 2019-12-31 | Skr41.40 Million ≈ $4.46 Million |
Skr-59.20 Million ≈ $-6.37 Million |
-1.430x | -22.49% |
| 2018-12-31 | Skr44.80 Million ≈ $4.82 Million |
Skr-52.30 Million ≈ $-5.63 Million |
-1.167x | -62.75% |
| 2017-12-31 | Skr85.57 Million ≈ $9.21 Million |
Skr-61.38 Million ≈ $-6.61 Million |
-0.717x | +37.73% |
| 2016-12-31 | Skr48.70 Million ≈ $5.24 Million |
Skr-56.10 Million ≈ $-6.04 Million |
-1.152x | -232.91% |
| 2015-12-31 | Skr109.93 Million ≈ $11.83 Million |
Skr-38.04 Million ≈ $-4.09 Million |
-0.346x | +57.54% |
| 2014-12-31 | Skr38.85 Million ≈ $4.18 Million |
Skr-31.66 Million ≈ $-3.41 Million |
-0.815x | -182.71% |
| 2013-12-31 | Skr71.61 Million ≈ $7.71 Million |
Skr-20.64 Million ≈ $-2.22 Million |
-0.288x | +53.27% |
| 2012-12-31 | Skr24.39 Million ≈ $2.62 Million |
Skr-15.05 Million ≈ $-1.62 Million |
-0.617x | -664.38% |
| 2011-12-31 | Skr48.50 Million ≈ $5.22 Million |
Skr-3.91 Million ≈ $-421.19K |
-0.081x | +60.69% |
| 2010-12-31 | Skr9.74 Million ≈ $1.05 Million |
Skr-2.00 Million ≈ $-215.09K |
-0.205x | -- |
About Episurf Medical AB (publ)
Episurf Medical AB (publ), a medical device company, designs and manufactures implants and surgical instruments in Germany, Sweden, rest of Europe, the United States, and internationally. It offers Episealer Knee for repairing focal cartilage and bone defects to reduce pain and increase mobility in the patient's knee joint; Episealer implant, which is designed to fit anatomy and size of the lesio… Read more